GLOBAL VASCULAR STENTS MARKET FORECAST 2018-2026
KEY FINDINGS
A networked tube of narrow, flexible rod elaborated with the use of alloys or stainless steel is called a vascular stent. It aids to restrict the blocking of arteries that can occur in patients that have gone through angioplasty. The growth of the vascular stent market is anticipated at 7.84% of CAGR throughout the forecasting years. The vascular stent market was globally valued at $ 1.32 billion in 2017 and is evolving rapidly in the coming years. Increasing number of the aging population across the globe is the essential driver proliferating the growth of the vascular stent market.
MARKET INSIGHTS
The types and products of vascular stents are deployed in varied purposes. The drug-eluting stents is to dominate the type segment during the forecast period. However, bioabsorbable stents are expected to grow fastest with 8.66% in the coming future. The products mentioned in the report are coronary, peripheral, Evar stent grafts. The vascular stents market also comprises of the mode of delivery, material and end-user segment. The various complications with the use of vascular stents is majorly affecting the growth of the market globally.
REGIONAL INSIGHTS
The global vascular stents market studies four key regions North America, Europe, Asia Pacific, and rest of world. The North America vascular stents market is to possess the highest share by the end of the forecasting years. Lifestyle-oriented diseases is the key factor responsible for the growth of the vascular stent market in the region. Nevertheless, Asia Pacific region is expected to grow at rapid pace majorly due to the increasing number of patients in the region which is also developing the market extensively.
COMPETITIVE INSIGHTS
The companies studied in the market for vascular stents are Abbott Laboratories, Biotronik Se & Co. Kg, Boston Scientific Corp., Braun Melsungen Ag, Endologix Inc, Lombard Medical Technologies Inc., Medtronic Inc., Meril Life Sciences Private Limited, Microport Scientific Corporation, Terumo Corporation, Translumina Gmbh, Vascular Concepts Limited (India), W.L. Gore and Associates, Inc. (U.S.).
A networked tube of narrow, flexible rod elaborated with the use of alloys or stainless steel is called a vascular stent. It aids to restrict the blocking of arteries that can occur in patients that have gone through angioplasty. The growth of the vascular stent market is anticipated at 7.84% of CAGR throughout the forecasting years. The vascular stent market was globally valued at $ 1.32 billion in 2017 and is evolving rapidly in the coming years. Increasing number of the aging population across the globe is the essential driver proliferating the growth of the vascular stent market.
MARKET INSIGHTS
The types and products of vascular stents are deployed in varied purposes. The drug-eluting stents is to dominate the type segment during the forecast period. However, bioabsorbable stents are expected to grow fastest with 8.66% in the coming future. The products mentioned in the report are coronary, peripheral, Evar stent grafts. The vascular stents market also comprises of the mode of delivery, material and end-user segment. The various complications with the use of vascular stents is majorly affecting the growth of the market globally.
REGIONAL INSIGHTS
The global vascular stents market studies four key regions North America, Europe, Asia Pacific, and rest of world. The North America vascular stents market is to possess the highest share by the end of the forecasting years. Lifestyle-oriented diseases is the key factor responsible for the growth of the vascular stent market in the region. Nevertheless, Asia Pacific region is expected to grow at rapid pace majorly due to the increasing number of patients in the region which is also developing the market extensively.
COMPETITIVE INSIGHTS
The companies studied in the market for vascular stents are Abbott Laboratories, Biotronik Se & Co. Kg, Boston Scientific Corp., Braun Melsungen Ag, Endologix Inc, Lombard Medical Technologies Inc., Medtronic Inc., Meril Life Sciences Private Limited, Microport Scientific Corporation, Terumo Corporation, Translumina Gmbh, Vascular Concepts Limited (India), W.L. Gore and Associates, Inc. (U.S.).
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. RISING INCIDENCE OF CARDIOVASCULAR DISORDERS
3.2.2. ADVANCES IN STENT TECHNOLOGY
3.2.3. NORTH AMERICA HOLDS THE LARGEST MARKET SHARE
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. INCIDENCE OF CARDIOVASCULAR DISEASES
4.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
4.1.3. ACCEPTANCE OF VASCULAR STENTS
4.1.4. FAST DEVELOPMENT IN THE GERIATRIC POPULACE
4.2. RESTRAINTS
4.2.1. DIFFICULTIES OF VASCULAR STENTS
4.2.2. PRODUCT FIASCOS AND RECALLS
4.2.3. THREAT OF ALTERNATIVES
4.3. MARKET OPPORTUNITIES
4.3.1. IMPROVEMENT OF THE STENTS ELEMENTS
4.3.2. MANDATE FROM EMERGING MARKETS IS SWELLING
4.4. MARKET CHALLENGES
4.4.1. STRINGENT REGULATORY FRAMEWORK
4.4.2. INTENSE COMPETITION
5. MARKET SEGMENTATION
5.1. MARKET BY TYPES 2018-2026
5.1.1. DRUG-ELUTING STENTS
5.1.2. BARE-METAL STENTS
5.1.3. BIOABSORBABLE STENT
5.2. MARKET BY PRODUCTS 2018-2026
5.2.1. CORONARY STENTS
5.2.2. PERIPHERAL STENTS
5.2.2.1. CAROTID ARTERY STENTS
5.2.2.2. RENAL ARTERY STENTS
5.2.2.3. FEMORAL ARTERY STENTS
5.2.2.4. OTHER PERIPHERAL STENTS
5.2.3. EVAR STENT GRAFTS
5.2.3.1. ABDOMINAL AORTIC ANEURYSM STENTS
5.2.3.2. THORACIC AORTIC ANEURYSM STENTS
5.3. MARKET BY MODE OF DELIVERY 2018-2026
5.3.1. BALLOON-EXPANDABLE STENTS
5.3.2. SELF-EXPANDING STENTS
5.4. MARKET BY MATERIALS 2018-2026
5.4.1. METALLIC STENTS
5.4.1.1. COBALT CHROMIUM
5.4.1.2. PLATINUM CHROMIUM
5.4.1.3. NICKEL TITANIUM
5.4.1.4. STAINLESS STEEL
5.4.2. OTHER MATERIAL
5.5. MARKET BY END USERS 2018-2026
5.5.1. HOSPITALS AND CARDIAC CENTERS
5.5.2. AMBULATORY SURGICAL CENTERS
6. KEY ANALYTICS
6.1. PORTERS FIVE FORCES ANALYSIS
6.1.1. BARGAINING POWER OF BUYERS
6.1.2. BARGAINING POWER OF SUPPLIERS
6.1.3. THREAT OF NEW ENTRANTS
6.1.4. THREAT OF SUBSTITUTES
6.1.5. THREAT OF RIVALRY
6.2. KEY BUYING CRITERIA
6.3. REGULATORY FRAMEWORK
6.4. VALUE CHAIN ANALYSIS
6.5. MARKET TRENDS
6.5.1. INTRODUCTION OF NEW PRODUCTS RELATED TO VASCULAR STENTS
6.5.2. HYBRID PROCEDURES ARE RISING SIGNIFICANTLY
6.5.3. TECHNOLOGY ADVANCEMENTS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. FRANCE
7.2.3. GERMANY
7.2.4. SPAIN
7.2.5. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. INDIA
7.3.3. JAPAN
7.3.4. AUSTRALIA
7.3.5. REST OF APAC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST & AFRICA
8. COMPANY PROFILES
8.1. COMPETITIVE LANDSCAPE
8.1.1. MARKET ANALYSIS
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC INITIATIVE
8.3. BIOTRONIK SE & CO. KG
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SWOT ANALYSIS
8.4. BOSTON SCIENTIFIC CORP.
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. SCOT ANALYSIS
8.4.4. STRATEGIC INITIATIVE
8.5. BRAUN MELSUNGEN AG
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SCOT ANALYSIS
8.5.4. STRATEGIC INITIATIVE
8.6. ENDOLOGIX INC
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC INITIATIVES
8.7. LOMBARD MEDICAL TECHNOLOGIES INC.
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. MEDTRONIC INC.
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVE
8.9. MERIL LIFE SCIENCES PRIVATE LIMITED
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.10. MICROPORT SCIENTIFIC CORPORATION
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SCOT ANALYSIS
8.10.4. STRATEGIC INITIATIVE
8.11. TERUMO CORPORATION
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.11.4. STRATEGIC INITIATIVE
8.12. TRANSLUMINA GMBH
8.12.1. COMPANY OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.13. VASCULAR CONCEPTS LIMITED (INDIA)
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. SCOT ANALYSIS
8.14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.14.4. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 GLOBAL VASCULAR STENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 BENEFITS OF MINIMALLY INVASIVE SURGERY
TABLE 3 GLOBAL VASCULAR STENTS MARKET, BY TYPE 2018-2026 ($ MILLION)
TABLE 4 GLOBAL VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 5 GLOBAL VASCULAR STENTS MARKET IN BARE-METAL STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 6 GLOBAL VASCULAR STENTS MARKET IN BIOABSORBABLE STENT BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 7 GLOBAL VASCULAR STENTS MARKET, BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 8 GLOBAL VASCULAR STENTS MARKET IN CORONARY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 GLOBAL VASCULAR STENTS MARKET IN CORONARY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 10 GLOBAL VASCULAR STENTS MARKET IN PERIPHERAL STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 11 GLOBAL VASCULAR STENTS MARKET IN PERIPHERAL STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 12 GLOBAL PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 13 GLOBAL PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 GLOBAL PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 15 GLOBAL PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 16 GLOBAL VASCULAR STENTS MARKET IN EVAR STENT GRAFTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 17 GLOBAL VASCULAR STENTS MARKET IN EVAR STENT GRAFTS BY TYPES 2018-2026 ($ MILLION)
TABLE 18 GLOBAL EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 19 GLOBAL EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 20 GLOBAL VASCULAR STENTS MARKET, BY MODE OF DELIVERY 2018-2026 ($ MILLION)
TABLE 21 GLOBAL VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 22 GLOBAL VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 23 GLOBAL VASCULAR STENTS MARKET, BY MATERIALS 2018-2026 ($ MILLION)
TABLE 24 GLOBAL VASCULAR STENTS MARKET IN METALLIC STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 25 GLOBAL VASCULAR STENTS MARKET IN METALLIC STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 26 GLOBAL METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
TABLE 27 GLOBAL METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
TABLE 28 GLOBAL METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
TABLE 29 GLOBAL METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
TABLE 30 GLOBAL VASCULAR STENTS MARKET IN OTHER MATERIAL BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 31 GLOBAL VASCULAR STENTS MARKET, BY END USERS 2018-2026 ($ MILLION)
TABLE 32 GLOBAL VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 33 GLOBAL VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 34 GLOBAL VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 35 GLOBAL VASCULAR STENTS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 36 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 37 EUROPE VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 38 ASIA PACIFIC VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 39 REST OF WORLD VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 40 DISEASES RELATED TO PREMATURE DEATH IN ARGENTINA
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. RISING INCIDENCE OF CARDIOVASCULAR DISORDERS
3.2.2. ADVANCES IN STENT TECHNOLOGY
3.2.3. NORTH AMERICA HOLDS THE LARGEST MARKET SHARE
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. INCIDENCE OF CARDIOVASCULAR DISEASES
4.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
4.1.3. ACCEPTANCE OF VASCULAR STENTS
4.1.4. FAST DEVELOPMENT IN THE GERIATRIC POPULACE
4.2. RESTRAINTS
4.2.1. DIFFICULTIES OF VASCULAR STENTS
4.2.2. PRODUCT FIASCOS AND RECALLS
4.2.3. THREAT OF ALTERNATIVES
4.3. MARKET OPPORTUNITIES
4.3.1. IMPROVEMENT OF THE STENTS ELEMENTS
4.3.2. MANDATE FROM EMERGING MARKETS IS SWELLING
4.4. MARKET CHALLENGES
4.4.1. STRINGENT REGULATORY FRAMEWORK
4.4.2. INTENSE COMPETITION
5. MARKET SEGMENTATION
5.1. MARKET BY TYPES 2018-2026
5.1.1. DRUG-ELUTING STENTS
5.1.2. BARE-METAL STENTS
5.1.3. BIOABSORBABLE STENT
5.2. MARKET BY PRODUCTS 2018-2026
5.2.1. CORONARY STENTS
5.2.2. PERIPHERAL STENTS
5.2.2.1. CAROTID ARTERY STENTS
5.2.2.2. RENAL ARTERY STENTS
5.2.2.3. FEMORAL ARTERY STENTS
5.2.2.4. OTHER PERIPHERAL STENTS
5.2.3. EVAR STENT GRAFTS
5.2.3.1. ABDOMINAL AORTIC ANEURYSM STENTS
5.2.3.2. THORACIC AORTIC ANEURYSM STENTS
5.3. MARKET BY MODE OF DELIVERY 2018-2026
5.3.1. BALLOON-EXPANDABLE STENTS
5.3.2. SELF-EXPANDING STENTS
5.4. MARKET BY MATERIALS 2018-2026
5.4.1. METALLIC STENTS
5.4.1.1. COBALT CHROMIUM
5.4.1.2. PLATINUM CHROMIUM
5.4.1.3. NICKEL TITANIUM
5.4.1.4. STAINLESS STEEL
5.4.2. OTHER MATERIAL
5.5. MARKET BY END USERS 2018-2026
5.5.1. HOSPITALS AND CARDIAC CENTERS
5.5.2. AMBULATORY SURGICAL CENTERS
6. KEY ANALYTICS
6.1. PORTERS FIVE FORCES ANALYSIS
6.1.1. BARGAINING POWER OF BUYERS
6.1.2. BARGAINING POWER OF SUPPLIERS
6.1.3. THREAT OF NEW ENTRANTS
6.1.4. THREAT OF SUBSTITUTES
6.1.5. THREAT OF RIVALRY
6.2. KEY BUYING CRITERIA
6.3. REGULATORY FRAMEWORK
6.4. VALUE CHAIN ANALYSIS
6.5. MARKET TRENDS
6.5.1. INTRODUCTION OF NEW PRODUCTS RELATED TO VASCULAR STENTS
6.5.2. HYBRID PROCEDURES ARE RISING SIGNIFICANTLY
6.5.3. TECHNOLOGY ADVANCEMENTS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. FRANCE
7.2.3. GERMANY
7.2.4. SPAIN
7.2.5. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. INDIA
7.3.3. JAPAN
7.3.4. AUSTRALIA
7.3.5. REST OF APAC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST & AFRICA
8. COMPANY PROFILES
8.1. COMPETITIVE LANDSCAPE
8.1.1. MARKET ANALYSIS
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC INITIATIVE
8.3. BIOTRONIK SE & CO. KG
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SWOT ANALYSIS
8.4. BOSTON SCIENTIFIC CORP.
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. SCOT ANALYSIS
8.4.4. STRATEGIC INITIATIVE
8.5. BRAUN MELSUNGEN AG
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SCOT ANALYSIS
8.5.4. STRATEGIC INITIATIVE
8.6. ENDOLOGIX INC
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC INITIATIVES
8.7. LOMBARD MEDICAL TECHNOLOGIES INC.
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. MEDTRONIC INC.
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVE
8.9. MERIL LIFE SCIENCES PRIVATE LIMITED
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.10. MICROPORT SCIENTIFIC CORPORATION
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SCOT ANALYSIS
8.10.4. STRATEGIC INITIATIVE
8.11. TERUMO CORPORATION
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.11.4. STRATEGIC INITIATIVE
8.12. TRANSLUMINA GMBH
8.12.1. COMPANY OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.13. VASCULAR CONCEPTS LIMITED (INDIA)
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. SCOT ANALYSIS
8.14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.14.4. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 GLOBAL VASCULAR STENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 BENEFITS OF MINIMALLY INVASIVE SURGERY
TABLE 3 GLOBAL VASCULAR STENTS MARKET, BY TYPE 2018-2026 ($ MILLION)
TABLE 4 GLOBAL VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 5 GLOBAL VASCULAR STENTS MARKET IN BARE-METAL STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 6 GLOBAL VASCULAR STENTS MARKET IN BIOABSORBABLE STENT BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 7 GLOBAL VASCULAR STENTS MARKET, BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 8 GLOBAL VASCULAR STENTS MARKET IN CORONARY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 GLOBAL VASCULAR STENTS MARKET IN CORONARY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 10 GLOBAL VASCULAR STENTS MARKET IN PERIPHERAL STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 11 GLOBAL VASCULAR STENTS MARKET IN PERIPHERAL STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 12 GLOBAL PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 13 GLOBAL PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 GLOBAL PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 15 GLOBAL PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 16 GLOBAL VASCULAR STENTS MARKET IN EVAR STENT GRAFTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 17 GLOBAL VASCULAR STENTS MARKET IN EVAR STENT GRAFTS BY TYPES 2018-2026 ($ MILLION)
TABLE 18 GLOBAL EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 19 GLOBAL EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 20 GLOBAL VASCULAR STENTS MARKET, BY MODE OF DELIVERY 2018-2026 ($ MILLION)
TABLE 21 GLOBAL VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 22 GLOBAL VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 23 GLOBAL VASCULAR STENTS MARKET, BY MATERIALS 2018-2026 ($ MILLION)
TABLE 24 GLOBAL VASCULAR STENTS MARKET IN METALLIC STENTS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 25 GLOBAL VASCULAR STENTS MARKET IN METALLIC STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 26 GLOBAL METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
TABLE 27 GLOBAL METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
TABLE 28 GLOBAL METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
TABLE 29 GLOBAL METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
TABLE 30 GLOBAL VASCULAR STENTS MARKET IN OTHER MATERIAL BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 31 GLOBAL VASCULAR STENTS MARKET, BY END USERS 2018-2026 ($ MILLION)
TABLE 32 GLOBAL VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 33 GLOBAL VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 34 GLOBAL VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 35 GLOBAL VASCULAR STENTS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 36 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 37 EUROPE VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 38 ASIA PACIFIC VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 39 REST OF WORLD VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
TABLE 40 DISEASES RELATED TO PREMATURE DEATH IN ARGENTINA
FIGURES LIST
FIGURE 1 GLOBAL VASCULAR STENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
FIGURE 2 HEART DISEASE DEATHS IN AMERICA 2017 (%)
FIGURE 3 GLOBAL VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL VASCULAR STENTS MARKET IN BARE-METAL STENTS 2018-2026 ($ MILLION)
FIGURE 5 GLOBAL VASCULAR STENTS MARKET IN BIOABSORBABLE STENT 2018-2026 ($ MILLION)
FIGURE 6 GLOBAL VASCULAR STENTS MARKET IN PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 7 GLOBAL PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS -2026 ($ MILLION)
FIGURE 9 GLOBAL PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS 2018-2026 ($ MILLION)
FIGURE 15 GLOBAL VASCULAR STENTS MARKET IN METALLIC STENTS 2018-2026 ($ MILLION)
FIGURE 16 GLOBAL METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
FIGURE 17 GLOBAL METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
FIGURE 18 GLOBAL METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
FIGURE 19 GLOBAL METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
FIGURE 20 GLOBAL VASCULAR STENTS MARKET IN OTHER MATERIAL BY GEOGRAPHY 2018-2026 ($ MILLION)
FIGURE 21 GLOBAL VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
FIGURE 22 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 23 UNITED STATES VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 24 CANADA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 25 EUROPE VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 26 UNITED KINGDOM VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 27 FRANCE VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 28 GERMANY VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 29 SPAIN VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 30 REST OF EUROPE VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 31 ASIA PACIFIC VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 32 CHINA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 33 INDIA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 34 JAPAN VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 35 AUSTRALIA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 36 REST OF APAC VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 37 REST OF WORLD VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 38 LATIN AMERICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 39 MIDDLE EAST & AFRICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
COMPANIES MENTIONED
2. ABBOTT LABORATORIES
3. BIOTRONIK SE & CO. KG
4. BOSTON SCIENTIFIC CORP.
5. BRAUN MELSUNGEN AG
6. ENDOLOGIX INC
7. LOMBARD MEDICAL TECHNOLOGIES INC.
8. MEDTRONIC INC.
9. MERIL LIFE SCIENCES PRIVATE LIMITED
10. MICROPORT SCIENTIFIC CORPORATION
11. TERUMO CORPORATION
12. TRANSLUMINA GMBH
13. VASCULAR CONCEPTS LIMITED (INDIA)
14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
FIGURE 1 GLOBAL VASCULAR STENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
FIGURE 2 HEART DISEASE DEATHS IN AMERICA 2017 (%)
FIGURE 3 GLOBAL VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL VASCULAR STENTS MARKET IN BARE-METAL STENTS 2018-2026 ($ MILLION)
FIGURE 5 GLOBAL VASCULAR STENTS MARKET IN BIOABSORBABLE STENT 2018-2026 ($ MILLION)
FIGURE 6 GLOBAL VASCULAR STENTS MARKET IN PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 7 GLOBAL PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS -2026 ($ MILLION)
FIGURE 9 GLOBAL PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS 2018-2026 ($ MILLION)
FIGURE 15 GLOBAL VASCULAR STENTS MARKET IN METALLIC STENTS 2018-2026 ($ MILLION)
FIGURE 16 GLOBAL METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
FIGURE 17 GLOBAL METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
FIGURE 18 GLOBAL METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
FIGURE 19 GLOBAL METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
FIGURE 20 GLOBAL VASCULAR STENTS MARKET IN OTHER MATERIAL BY GEOGRAPHY 2018-2026 ($ MILLION)
FIGURE 21 GLOBAL VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
FIGURE 22 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 23 UNITED STATES VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 24 CANADA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 25 EUROPE VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 26 UNITED KINGDOM VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 27 FRANCE VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 28 GERMANY VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 29 SPAIN VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 30 REST OF EUROPE VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 31 ASIA PACIFIC VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 32 CHINA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 33 INDIA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 34 JAPAN VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 35 AUSTRALIA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 36 REST OF APAC VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 37 REST OF WORLD VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 38 LATIN AMERICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 39 MIDDLE EAST & AFRICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
COMPANIES MENTIONED
2. ABBOTT LABORATORIES
3. BIOTRONIK SE & CO. KG
4. BOSTON SCIENTIFIC CORP.
5. BRAUN MELSUNGEN AG
6. ENDOLOGIX INC
7. LOMBARD MEDICAL TECHNOLOGIES INC.
8. MEDTRONIC INC.
9. MERIL LIFE SCIENCES PRIVATE LIMITED
10. MICROPORT SCIENTIFIC CORPORATION
11. TERUMO CORPORATION
12. TRANSLUMINA GMBH
13. VASCULAR CONCEPTS LIMITED (INDIA)
14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
